Related Experiment Video

Updated: Jan 17, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.9K

Boosting astrocytic NAD+ against tauopathy

Zheng Chen1, Seung-Hee Yoo2

  • 1Department of Biochemistry and Molecular Biology, McGovern Medical School, UT Health Science Center at Houston, Houston, TX, USA. Zheng.chen.1@uth.tmc.edu.

Nature Aging
|September 22, 2025
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.6K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K

Related Experiment Videos

Last Updated: Jan 17, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.9K
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.6K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

560
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
560
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825

Articles linked to this work by shared authors, journal, and citation graph.

DHHC3-dependent S-Acylation of CRY1 regulates its subcellular localization and repressor function in the circadian clock.

bioRxiv : the preprint server for biology·2026

FBXL21 regulates diurnal proteostasis and stress response by targeting DNAJB6 and client proteins.

bioRxiv : the preprint server for biology·2026

Cryptochrome Loss Drives COPD-like Lung Pathology through Disrupted Alveolar Epithelial Proliferation and Immune Homeostasis.

bioRxiv : the preprint server for biology·2026

BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury.

Nature·2025

Fructose induces inflammatory activation in macrophages and microglia through the nutrient-sensing ghrelin receptor.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025

The BMAL1/HIF2A heterodimer modulates circadian variations of myocardial injury.

Research square·2024

Three-dimensional mapping of intact ovaries reveals the aging dynamics of the ovarian reserve.

Nature aging·2026

TNFR1 signaling connects inflammation to impaired fatty acid oxidation to drive intestinal stem cell aging.

Nature aging·2026

Agentic AI for scaling diagnosis and care in neurodegenerative disease.

Nature aging·2026

Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset.

Nature aging·2026

The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming.

Nature aging·2026

Bioengineering strategies to interrogate and modulate the aging immune system.

Nature aging·2026

Thymosin β4 Mitigates Acute Cerebral Infarction Via Inhibition of the TLR4/NF-κB Pathway and Suppression of Neuronal Pyroptosis.

Applied biochemistry and biotechnology·2026

How higher-order interactions shape the dynamics of large-scale dual-star neural networks.

Chaos (Woodbury, N.Y.)·2026

A potential neuroimaging biomarker for depression in migraine patients: imbalance in excitation and inhibition in the medial superior frontal cortex.

Journal of psychiatry & neuroscience : JPN·2026

Development and internal validation of an XGBoost-based prognostic prediction model and risk stratification system for overall survival in pediatric neuroblastoma: a SEER-based study.

Translational pediatrics·2026

Whole-brain input organization of Kremen1-positive striatal spiny projection neurons revealed by monosynaptic rabies tracing.

Frontiers in neural circuits·2026

NeuroSPFNet: Vision-Language Semantic Prior-Guided Frequency-Enhanced Network for Brain Tumor Segmentation in Multimodal MRI.

Sensors (Basel, Switzerland)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us